420 Insight

JUNE 15, 2015

Sickle cell disease (SCD) is a hereditary condition caused by a mutation in the haemoglobin gene, which leads to symptoms of anaemia, extreme pain, and organ damage if unmanaged. Individuals suffering from SCD are far more likely to use cannabis than the general population, potentially for its analgesic properties. What is Sickle Cell Disease? In SCD, a mutation in the haemoglobin gene causes red blood cells to become distorted, from the usual pliable, concave disc to a rigid, sickle-shaped form

Conditions 74

Conditions Cannabis Treatment Medicine 74

420 Insight

JUNE 17, 2015

Parkinson’s Disease (PD) is a motor system disorder classified as a progressive neurological disease which occurs when neurons in the basal ganglia degenerate, causing a shortage of dopamine production. This results in the impairments in movement associated with the disease. Parkinson’s typically affects men over 60, but — as Michael J. Fox has unfortunately proven — can afflict significantly younger adults.

Cannabinoids 49

Cannabinoids Treatment Sleep Cannabis 49

420 Insight

JUNE 25, 2015

Considering treating your migraine or headache disorder with medical cannabis? It’s a complicated topic with a variety of perspectives, so I’ve tried to distill some of the most important information below. I hope it’s a helpful guide. Marijuana’s Efficacy for Migraine or Headache Disorders. Because laws make research of medical marijuana very difficult, there have been no blinded studies on its use for migraine or headache disorders.

Strains 44

Strains Cannabis Dispensary Topical 44

420 Insight

JUNE 2, 2015

Autism Spectrum Disorder (ASD) is a developmental disorder that appears within the first 3 years of life. ASD most commonly affects communication and social skills. The cause of the disorder is not known but is linked to abnormal brain chemistry. Research into the source of ASD is very active though medications have only been developed to deal with the behavioral consequences of the disorder, not the disorder itself.

Pharmaceutical 42

Pharmaceutical Research and Development Cannabinoids Cannabis 42

Speaker: Jonathan Bench, International Cannabis and Securities Business Attorney at Harris Bricken

The U.S. cannabis industry is still in its infancy, even though states began engaging with legalization in one form or another in the late 1990s. Today, many opportunities exist for individuals and businesses that want to engage in the industry. Some want to directly own licensed businesses, while others prefer to keep the industry at an arm’s length and merely profit from it.

Cannabis